Press Releases Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Delayed Canadian Securities Exchange Other stock markets 08:11:19 06/05/2024 pm IST			5-day change	1st Jan Change
0.165 ^CAD	-23.26%		0.00%	+65.00%

29/04	Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024	CI
18/04	Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Entheon Biomedical : CFO Certification	27/22/27	PU
Entheon Biomedical : CEO Certification	27/22/27	PU
Entheon Biomedical : Quarterly Report	27/22/27	PU
Entheon Biomedical : CFO Certification	31/22/31	PU
Entheon Biomedical : CEO Certification	31/22/31	PU
Entheon Biomedical Announces Expanded Psychedelics Genetic Test Panel & New Clinical Research Platform	30/22/30	AQ
Entheon Biomedical Announces Participation in the Benzinga Global Small Cap Conference	04/21/04	NE
BTV Investor Alert Video: Entheon Biomedical Corp. - Treating Addiction	23/21/23	NE
Microdose Psychedelic Insights Announces Entheon Biomedical, Levitee Labs, and Women in Psychedelics to take centre stage at Psychedelic Capital: September 30, 2021	23/21/23	NE
Leading DMT Companies to Take Stage at Molecular Masterclass: DMT Conference	01/21/01	NE
Entheon Biomedical : Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics	30/21/30	AQ
Clinical Director of Imperial College's Center for Psychedelic Research Joins Entheon Advisory Board	25/21/25	NE
Entheon Biomedical Corp. Announces DTC Eligibility	24/21/24	NE
Entheon Biomedical Announces Sponsorship of a Clinical Study to Assess the Electroneurophysiologic Effects of Ketamine	12/21/12	NE
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.	30/21/30	NE
Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw	28/21/28	NE
Microdose Is Pleased to Announce the DMT Conference: A Molecular Masterclass	27/21/27	NE
Entheon Biomedical Announces Medical Advisor, Dr. Dinesh Bhayana	30/21/30	NE
Entheon Subsidiary, HaluGen Life Sciences, Partners with Maya Health to Drive Psychedelics Genetic Test Kit Awareness	25/21/25	NE
Entheon Biomedical : Subsidiary HaluGen Life Sciences Announces Agreement with Third Wave	23/21/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Entheon Biomedical Corp.

Equities

ENBI

CA29383X2023

Press Releases

Filters